Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06281496 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT06281496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06281496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2024
Completion date
December 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological diseases